India DCGI Accuses CMO Of Submitting All-False Data For Seven Drugs
This article was originally published in PharmAsia News
Executive Summary
GuruFcure, a contract manufacturer that says its clients included Abbott Laboratories, Glenmark and Wockhardt, has been accused by the Drug Controller General of India of submitting false data for seven combination drugs it made.